JP2004530731A5 - - Google Patents

Download PDF

Info

Publication number
JP2004530731A5
JP2004530731A5 JP2003510034A JP2003510034A JP2004530731A5 JP 2004530731 A5 JP2004530731 A5 JP 2004530731A5 JP 2003510034 A JP2003510034 A JP 2003510034A JP 2003510034 A JP2003510034 A JP 2003510034A JP 2004530731 A5 JP2004530731 A5 JP 2004530731A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003510034A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004530731A (ja
Filing date
Publication date
Priority claimed from DE10134775A external-priority patent/DE10134775A1/de
Application filed filed Critical
Publication of JP2004530731A publication Critical patent/JP2004530731A/ja
Publication of JP2004530731A5 publication Critical patent/JP2004530731A5/ja
Pending legal-status Critical Current

Links

JP2003510034A 2001-07-06 2002-07-06 1−アルキル−2−アリール−ベンズイミダゾール誘導体、医薬製剤の製造のためへのそれらの使用、及びそれらの誘導体を含む医薬製剤 Pending JP2004530731A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10134775A DE10134775A1 (de) 2001-07-06 2001-07-06 1-Alkyl-2.aryl-benzimidazolderivate, deren Verwendung zur Herstellung von Arzneimitteln sowie diese Derivate enthaltende pharmazeutische Präparate
PCT/EP2002/007597 WO2003004023A1 (de) 2001-07-06 2002-07-06 1-alkyl-2-aryl-benzimidazolderivate, deren verwendung zur herstellung von arzneimitteln sowie diese derivate enthaltende pharmazeutische präparate

Publications (2)

Publication Number Publication Date
JP2004530731A JP2004530731A (ja) 2004-10-07
JP2004530731A5 true JP2004530731A5 (pt) 2009-10-01

Family

ID=7692119

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003510034A Pending JP2004530731A (ja) 2001-07-06 2002-07-06 1−アルキル−2−アリール−ベンズイミダゾール誘導体、医薬製剤の製造のためへのそれらの使用、及びそれらの誘導体を含む医薬製剤

Country Status (4)

Country Link
EP (1) EP1404321A1 (pt)
JP (1) JP2004530731A (pt)
DE (1) DE10134775A1 (pt)
WO (1) WO2003004023A1 (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10207843A1 (de) * 2002-02-15 2003-09-04 Schering Ag Mikrolia-Inhibitoren zur Unterbrechung von Interleukin 12 und IFN-gamma vermittelten Immunreaktionen
CN101870691A (zh) 2002-08-19 2010-10-27 劳洛斯治疗公司 2,4,5-三取代的咪唑及其作为抗菌剂的用途
US7582761B2 (en) 2002-10-17 2009-09-01 Amgen Inc. Vanilloid receptor ligands and their use in treatments
US8969372B2 (en) 2003-11-14 2015-03-03 Aptose Boisciences Inc. Aryl imidazoles and their use as anti-cancer agents
DE102004026590A1 (de) * 2004-06-01 2006-01-12 Siemens Ag Assistenzsystem für Kraftfahrzeuge
CN101248072B (zh) 2005-05-25 2013-01-23 劳洛斯治疗公司 2-吲哚基咪唑并[4,5-d]菲咯啉衍生物及其在癌症治疗中的用途
EP2350032B1 (en) * 2008-09-26 2016-05-25 Eisai R&D Management Co., Ltd. Benzoxazole compounds and methods of use
BRPI0919816A2 (pt) * 2008-09-26 2019-09-24 Eisai R&D Man Co Ltd uso compostos benzoxazólicos no tratamento de malária
EP2501696B1 (en) * 2009-10-15 2016-12-28 Guerbet Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
US9309247B2 (en) 2013-03-20 2016-04-12 Lorus Therapeutics Inc. 2-substituted imidazo[4,5-D]phenanthroline derivatives and their use in the treatment of cancer
EP3052102B1 (en) 2013-10-04 2019-12-04 Aptose Biosciences Inc. Compositions for treating cancers
PT3390367T (pt) * 2015-12-15 2020-09-23 Univ Leland Stanford Junior Método para prevenir e/ou tratar enfraquecimento cognitivo e neuroinflamação associados ao envelhecimento
TW201936190A (zh) 2017-10-30 2019-09-16 加拿大商艾普托斯生物科學公司 用於治療癌症之芳基咪唑

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4330959A1 (de) * 1993-09-09 1995-03-16 Schering Ag Neue Benzimidazolderivate, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
US5552426A (en) * 1994-04-29 1996-09-03 Eli Lilly And Company Methods for treating a physiological disorder associated with β-amyloid peptide
PT1246808E (pt) * 2000-01-14 2011-11-30 Bayer Schering Pharma Ag 1,2¿diarilbenzimidazol para o tratamento de doenças associadas a uma activação das micróglias

Similar Documents

Publication Publication Date Title
JP2004532269A5 (pt)
JP2004537984A5 (pt)
JP2006514019A5 (pt)
JP2004244619A5 (pt)
JP2004168997A5 (pt)
JP2003305787A5 (pt)
JP2005533836A5 (pt)
JP2003193065A5 (pt)
JP2006510481A5 (pt)
JP2003321523A5 (pt)
JP2004155888A5 (pt)
JP2004188303A5 (pt)
JP2004262980A5 (pt)
JP2005523387A5 (pt)
JP2004530731A5 (pt)
JP2005532980A5 (pt)
JP2003007517A5 (pt)
JP2004522835A5 (pt)
JP2004537572A5 (pt)
JP2004518010A5 (pt)
JP2005002267A5 (pt)
JP2003268293A5 (pt)
JP2005000126A5 (pt)
JP2003073555A5 (pt)
JP2003073772A5 (pt)